Suppr超能文献

三阴性乳腺癌患者的临床特征

Clinical Characteristics in Patients with Triple Negative Breast Cancer.

作者信息

Yeh Janet, Chun Jennifer, Schwartz Shira, Wang Annie, Kern Elizabeth, Guth Amber A, Axelrod Deborah, Shapiro Richard, Schnabel Freya

机构信息

Department of Surgery, New York University Langone Medical Center, New York, NY, USA.

School of Medicine, New York University Langone Medical Center, New York, NY, USA.

出版信息

Int J Breast Cancer. 2017;2017:1796145. doi: 10.1155/2017/1796145. Epub 2017 Aug 17.

Abstract

PURPOSE

The purpose of this study was to compare and contrast the clinical characteristics of the triple negative breast cancer (TNBC) and non-TNBC patients, with a particular focus on genetic susceptibility and risk factors prior to diagnosis.

METHODS

Our institutional database was queried for all patients diagnosed with invasive breast cancer between January 2010 and May 2016.

RESULTS

Out of a total of 1964 patients, 190 (10%) patients had TNBC. The median age for both TNBC and non-TNBC was 59 years. There was a significantly higher proportion of African American and Asian patients with TNBC ( = 0.0003) compared to patients with non-TNBC. BRCA1 and BRCA2 were significantly associated with TNBC ( < 0.0001, = 0.0007). A prior history of breast cancer was significantly associated with TNBC ( = 0.0003). There was no relationship observed between TNBC and a history of chemoprevention or patients who had a history of AH or LCIS.

CONCLUSIONS

We found that having Asian ancestry, a prior history of breast cancer, and a BRCA1 or BRCA2 mutation all appear to be positively associated with TNBC. In order to develop more effective treatments, better surveillance, and improved prevention strategies, it is necessary to improve our understanding of the population at risk for TNBC.

摘要

目的

本研究旨在比较和对比三阴性乳腺癌(TNBC)和非TNBC患者的临床特征,特别关注诊断前的遗传易感性和风险因素。

方法

查询我们机构数据库中2010年1月至2016年5月期间所有诊断为浸润性乳腺癌的患者。

结果

在总共1964例患者中,190例(10%)为TNBC患者。TNBC和非TNBC患者的中位年龄均为59岁。与非TNBC患者相比,TNBC患者中非洲裔美国人和亚洲人的比例显著更高(P = 0.0003)。BRCA1和BRCA2与TNBC显著相关(P < 0.0001,P = 0.0007)。乳腺癌既往史与TNBC显著相关(P = 0.0003)。未观察到TNBC与化学预防史或有非典型增生(AH)或小叶原位癌(LCIS)病史的患者之间存在关联。

结论

我们发现亚洲血统、乳腺癌既往史以及BRCA1或BRCA2突变似乎均与TNBC呈正相关。为了开发更有效的治疗方法、更好的监测手段和改进预防策略,有必要加深我们对TNBC高危人群的了解。

相似文献

1
Clinical Characteristics in Patients with Triple Negative Breast Cancer.
Int J Breast Cancer. 2017;2017:1796145. doi: 10.1155/2017/1796145. Epub 2017 Aug 17.
3
Contribution of BRCA1 5382insC mutation in triple negative breast cancer in Tunisia.
J Transl Med. 2019 Apr 11;17(1):123. doi: 10.1186/s12967-019-1873-8.
5
The relationship of breast density in mammography and magnetic resonance imaging in women with triple negative breast cancer.
Eur J Radiol. 2020 Mar;124:108813. doi: 10.1016/j.ejrad.2020.108813. Epub 2020 Jan 7.
7
Clinicopathological and Molecular Study of Triple-Negative Breast Cancer in Algerian Patients.
Pathol Oncol Res. 2018 Apr;24(2):297-308. doi: 10.1007/s12253-017-0242-2. Epub 2017 May 6.
9
Evaluation of BRCA1 mutations in an unselected patient population with triple-negative breast cancer.
Breast Cancer Res Treat. 2013 Jan;137(1):119-25. doi: 10.1007/s10549-012-2348-2. Epub 2012 Nov 29.

引用本文的文献

2
Correlation between BRCA1 expression and the advanced stage of triple‑negative breast cancer.
Mol Clin Oncol. 2025 Jan 30;22(4):32. doi: 10.3892/mco.2025.2827. eCollection 2025 Apr.
4
Efficacy of metformin and electrical pulses in breast cancer MDA-MB-231 cells.
Explor Target Antitumor Ther. 2024;5(1):54-73. doi: 10.37349/etat.2024.00204. Epub 2024 Feb 19.
6
High rate of epidermal growth factor receptor-mutated primary lung cancer in patients with primary breast cancer.
Front Oncol. 2022 Oct 13;12:985734. doi: 10.3389/fonc.2022.985734. eCollection 2022.
8
Triple negative breast cancer: approved treatment options and their mechanisms of action.
J Cancer Res Clin Oncol. 2023 Jul;149(7):3701-3719. doi: 10.1007/s00432-022-04189-6. Epub 2022 Aug 17.
9
Dynamics of tumor-associated macrophages in a quantitative systems pharmacology model of immunotherapy in triple-negative breast cancer.
iScience. 2022 Jun 30;25(8):104702. doi: 10.1016/j.isci.2022.104702. eCollection 2022 Aug 19.
10
Evolving Evidence for the Optimization of Neoadjuvant Therapy in Triple-Negative Breast Cancer.
Breast Cancer (Auckl). 2022 Jun 27;16:11782234221107580. doi: 10.1177/11782234221107580. eCollection 2022.

本文引用的文献

1
Chemoprevention for Breast Cancer.
Ann Surg Oncol. 2015 Oct;22(10):3230-5. doi: 10.1245/s10434-015-4715-9. Epub 2015 Jul 23.
4
The prevalence of BRCA1 and BRCA2 mutations among young Mexican women with triple-negative breast cancer.
Breast Cancer Res Treat. 2015 Apr;150(2):389-94. doi: 10.1007/s10549-015-3312-8. Epub 2015 Feb 26.
5
Atypical hyperplasia of the breast--risk assessment and management options.
N Engl J Med. 2015 Jan 1;372(1):78-89. doi: 10.1056/NEJMsr1407164.
6
The 2014 Society of Surgical Oncology Susan G. Komen for the Cure Symposium: triple-negative breast cancer.
Ann Surg Oncol. 2015 Mar;22(3):874-82. doi: 10.1245/s10434-014-4279-0. Epub 2014 Dec 20.
7
A study of triple negative breast cancer at a tertiary cancer care center in southern India.
Ann Med Health Sci Res. 2014 Nov;4(6):933-7. doi: 10.4103/2141-9248.144917.
8
Tamoxifen for prevention of breast cancer: extended long-term follow-up of the IBIS-I breast cancer prevention trial.
Lancet Oncol. 2015 Jan;16(1):67-75. doi: 10.1016/S1470-2045(14)71171-4. Epub 2014 Dec 11.
9
Acceptance and adherence to chemoprevention among women at increased risk of breast cancer.
Breast. 2015 Feb;24(1):51-6. doi: 10.1016/j.breast.2014.11.006. Epub 2014 Dec 6.
10
Triple negative breast cancer in people of North East India: critical insights gained at a regional cancer centre.
Asian Pac J Cancer Prev. 2014;15(11):4507-11. doi: 10.7314/apjcp.2014.15.11.4507.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验